The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Sandoz Pharmaceuticals
Approval Status: Approved November 1996
Treatment for: cold symptoms, including sneezing and runny nose
General Information
Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.